COQ6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.568400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.127800E-01
Normal-vs-Stage2
4.328600E-01
Normal-vs-Stage3
1.347550E-01
Normal-vs-Stage4
6.527600E-01
Stage1-vs-Stage2
9.731500E-02
Stage1-vs-Stage3
7.808100E-02
Stage1-vs-Stage4
4.835000E-01
Stage2-vs-Stage3
3.505500E-02
Stage2-vs-Stage4
8.725600E-01
Stage3-vs-Stage4
1.516600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.246000E-01
Normal-vs-AfricanAmerican
2.002000E-01
Normal-vs-Asian
2.752600E-01
Caucasian-vs-AfricanAmerican
2.999600E-01
Caucasian-vs-Asian
2.161200E-01
AfricanAmerican-vs-Asian
8.986200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.524600E-01
Normal-vs-Female
7.667800E-01
Male-vs-Female
4.868000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.187200E-01
Normal-vs-Age(41-60Yrs)
9.398200E-01
Normal-vs-Age(61-80Yrs)
4.909200E-01
Normal-vs-Age(81-100Yrs)
7.995600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.289800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.659000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.354800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.419800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.695600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.811200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.534800E-01
Normal-vs-Daily Drinker
8.615800E-01
Normal-vs-Weekly Drinker
3.867600E-01
Normal-vs-Occasional Drinker
8.973000E-01
Normal-vs-Social Drinker
9.504600E-01
Non Drinker-vs-Daily Drinker
1.787980E-01
Non Drinker-vs-Weekly Drinker
9.088800E-01
Non Drinker-vs-Occasional Drinker
1.245020E-01
Non Drinker-vs-Social Drinker
3.031000E-01
Daily Drinker-vs-Weekly Drinker
2.599000E-01
Daily Drinker-vs-Occasional Drinker
5.678400E-01
Daily Drinker-vs-Social Drinker
8.845000E-01
Weekly Drinker-vs-Occasional Drinker
1.653220E-01
Weekly Drinker-vs-Social Drinker
3.172600E-01
Occasional Drinker-vs-Social Drinker
7.389800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.747600E-01
Normal-vs-Grade 2
8.126800E-01
Normal-vs-Grade 3
7.909200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.795820E-01
Grade 1-vs-Grade 3
2.594600E-01
Grade 1-vs-Grade 4
4.747600E-01
Grade 2-vs-Grade 3
5.575600E-01
Grade 2-vs-Grade 4
8.126800E-01
Grade 3-vs-Grade 4
7.909200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.639200E-01
Normal-vs-NonDiabetic
7.560600E-01
Diabetic-vs-NonDiabetic
1.771620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.490200E-01
Normal-vs-NoPancreatitis
6.729800E-01
Pancreatitis-vs-NoPancreatitis
5.084800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.549800E-01
Normal-vs-N1
4.276600E-01
N0-vs-N1
8.998200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.188000E-01
Normal-vs-TP53-NonMutant
8.567000E-01
TP53-Mutant-vs-TP53-NonMutant
7.124200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
